136 related articles for article (PubMed ID: 38286882)
21. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer: A long way to go.
Zhao P; Li S; Du X
Eur J Cancer; 2024 Mar; 199():113554. PubMed ID: 38237372
[No Abstract] [Full Text] [Related]
22. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
23. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
[TBL] [Abstract][Full Text] [Related]
24. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
25. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
[TBL] [Abstract][Full Text] [Related]
26. Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer.
Yonemura Y; Ishibashi H; Hirano M; Mizumoto A; Takeshita K; Noguchi K; Takao N; Ichinose M; Liu Y; Li Y
Ann Surg Oncol; 2017 Feb; 24(2):478-485. PubMed ID: 27506661
[TBL] [Abstract][Full Text] [Related]
27. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial.
Liu Y; Endo Y; Fujita T; Ishibashi H; Nishioka T; Canbay E; Li Y; Ogura S; Yonemura Y
Ann Surg Oncol; 2014 Dec; 21(13):4256-62. PubMed ID: 25056850
[TBL] [Abstract][Full Text] [Related]
29. ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Tonello M; Sommariva A
Ann Surg Oncol; 2022 Jun; 29(6):3418-3419. PubMed ID: 34743279
[No Abstract] [Full Text] [Related]
30. Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice.
Arjona-Sánchez Á; Durán M; Sánchez-Hidalgo JM; Rufian-Peña S
Surg Oncol; 2019 Dec; 31():14-15. PubMed ID: 31472328
[No Abstract] [Full Text] [Related]
31. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y
Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938
[TBL] [Abstract][Full Text] [Related]
32. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2015 May; 22(5):1673-9. PubMed ID: 25377640
[TBL] [Abstract][Full Text] [Related]
33. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer.
Liu L; Sun L; Zhang N; Liao CG; Su H; Min J; Song Y; Yang X; Huang X; Chen D; Chen Y; Zhang HW; Zhang H
Int J Hyperthermia; 2022; 39(1):239-245. PubMed ID: 35100917
[TBL] [Abstract][Full Text] [Related]
34. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
35. Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies.
Choudry MH; Bartlett DL; Alexander HR; Turaga KK
Ann Surg Oncol; 2020 Jan; 27(1):73-75. PubMed ID: 31646448
[No Abstract] [Full Text] [Related]
36. Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
Kim JW; Choi SH
Eur J Surg Oncol; 2016 Nov; 42(11):1760-1761. PubMed ID: 27683051
[No Abstract] [Full Text] [Related]
37. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.
Glehen O; Passot G; Villeneuve L; Vaudoyer D; Bin-Dorel S; Boschetti G; Piaton E; Garofalo A
BMC Cancer; 2014 Mar; 14():183. PubMed ID: 24628950
[TBL] [Abstract][Full Text] [Related]
38. Enigma of Hyperthermic Intraperitoneal Chemotherapy with Interval Cytoreduction Surgery: Need to Push More Boundaries!
Raghavan S; Patel S; Prem A; Pandey D
Ann Surg Oncol; 2022 May; 29(5):3355-3356. PubMed ID: 35187619
[No Abstract] [Full Text] [Related]
39. Reply to: Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
Wu HT; Li Y
Eur J Surg Oncol; 2016 Nov; 42(11):1762-1766. PubMed ID: 27567099
[No Abstract] [Full Text] [Related]
40. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]